VIKING THERAPEUTICS INC's ticker is VKTX and the CUSIP is 92686J106. A total of 203 filers reported holding VIKING THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is 0.48 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2023 | $182,800 | +27.0% | 10,000 | -23.1% | 0.04% | +15.6% |
Q3 2023 | $143,910 | -28.3% | 13,000 | 0.0% | 0.03% | -27.3% |
Q2 2023 | $200,720 | -13.9% | 13,000 | -7.1% | 0.04% | -18.5% |
Q1 2023 | $233,100 | +36.7% | 14,000 | -31.0% | 0.05% | +35.0% |
Q4 2022 | $170,520 | +215.8% | 20,300 | +1.5% | 0.04% | +166.7% |
Q3 2022 | $54,000 | +12.5% | 20,000 | +17.6% | 0.02% | +25.0% |
Q2 2022 | $48,000 | – | 17,000 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
APIS CAPITAL ADVISORS, LLC | 148,000 | $1,638,360 | 2.12% |
Sio Capital Management, LLC | 595,002 | $6,586,672 | 2.04% |
5AM Venture Management, LLC | 585,000 | $6,475,950 | 1.86% |
Artia Global Partners LP | 383,580 | $4,246,231 | 1.76% |
Integral Health Asset Management, LLC | 800,000 | $8,856,000 | 1.23% |
Boxer Capital, LLC | 2,000,000 | $22,140,000 | 1.18% |
DAFNA Capital Management LLC | 319,655 | $3,538,581 | 1.10% |
Affinity Asset Advisors, LLC | 332,600 | $3,681,882 | 1.04% |
MPM BioImpact LLC | 325,000 | $3,597,750 | 0.96% |
Affinity Asset Advisors, LLC | 300,000 | $3,321,000 | 0.93% |